P Bitterman
Overview
Explore the profile of P Bitterman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
388
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Massad S, Kirstein L, Darragh T, Bitterman P, Sidawy M, Muderspach L, et al.
J Low Genit Tract Dis
. 2015 May;
4(4):190-4.
PMID: 25951153
Objectives: To determine interrater variability in classifying cervical biopsies from women with human immunodeficiency virus (HIV). Materials And Methods: Cervical biopsies performed on women participating in the Women's Interagency HIV...
2.
Anderson J, Behbakht K, De Geest K, Bitterman P
Obstet Gynecol
. 2001 Nov;
98(5 Pt 2):964-6.
PMID: 11704223
Background: Adenosarcoma in a patient with extraovarian endometriosis is a rare event and can be easily overlooked. Case: A woman with a history of endometriosis underwent multiple resections of a...
3.
Braithwaite S, Bitterman P, DeGeest K, Lebbin D
Endocr Pract
. 2001 Mar;
7(1):40-3.
PMID: 11250768
Objective: To report a case of virilizing ovarian hilus cell hyperplasia detected postmenopausally in association with a simple cyst and to review the related literature, including four similar cases. Methods:...
4.
Idell S, Mazar A, Bitterman P, Mohla S, Harabin A
Am J Respir Crit Care Med
. 2001 Feb;
163(2):578-84.
PMID: 11179137
No abstract available.
5.
Tan A, Bitterman P, Sonenberg N, Peterson M, Polunovsky V
Oncogene
. 2000 Mar;
19(11):1437-47.
PMID: 10723135
Ectopically expressed eukaryotic translation initiation factor 4E (eIF4E) stimulates cell proliferation, suppresses apoptosis in growth factor restricted cells, and induces malignant transformation in primary rodent fibroblasts when coexpressed with protooncogene...
6.
Fitzgerald M, Mollenhauer J, Bitterman P, Brubaker L
Am J Obstet Gynecol
. 1999 Dec;
181(6):1339-44; discussion 1344-6.
PMID: 10601910
Objectives: Fascia lata allografts are commonly used in urogynecologic procedures. Functional failure of several grafts has occurred, and such failure has been recognized as a materials problem in 12 patients....
7.
Massad L, Ahuja J, Bitterman P
Gynecol Oncol
. 1999 May;
73(2):315-8.
PMID: 10329053
Verrucous carcinomas of the vulva are rare and have not been reported in women infected with the human immunodeficiency virus. We present such a case in a 32-year-old woman characterized...
8.
David O, Green L, Reddy V, Kluskens L, Bitterman P, Attal H, et al.
Diagn Cytopathol
. 1998 Dec;
19(6):423-7.
PMID: 9839131
Only 15% of primary malignant tumors are confined to the gland at the time of presentation. Fine-needle aspiration (FNA) is valuable in confirming the malignant nature of these unresectable lesions....
9.
Zaino R, Kurman R, Brunetto V, Morrow C, Bentley R, Cappellari J, et al.
Am J Surg Pathol
. 1998 Nov;
22(11):1379-85.
PMID: 9808130
Papillary endometrioid or villoglandular adenocarcinoma (VGA) is a relatively common type of endometrial adenocarcinoma, but studies describing its behavior have yielded conflicting results. Patients with a component of VGA were...
10.
Rubins J, Greatens T, Kratzke R, Tan A, Polunovsky V, Bitterman P
Am J Respir Crit Care Med
. 1998 May;
157(5 Pt 1):1616-22.
PMID: 9603146
Malignant mesothelioma causes profound morbidity and nearly universal mortality that is refractory to conventional treatment with aggressive surgery, radiotherapy, or chemotherapy. We report that pharmacologic concentrations of lovastatin, a 3-hydroxy-3-methylglutaryl...